Targeted Strategies for Today's Evolving Markets

MissionIR Blog

Monthly Archives: August 2022

Cepton, Inc. (NASDAQ: CPTN) Announces New COO Appointment; Reveals Attendance at J.P. Morgan Auto Conference

Dr. Liqun Han has been appointed as Cepton’s COO, having led the Company’s product development, commercialization, and operations teams over the past several years The announcement marks a momentous year for the Company, with Cepton recently revealing that it had … Continue reading

Posted in Cepton Inc. CPTN | Leave a comment

Lexaria Bioscience Corp. (NASDAQ: LEXX) Enters Four Partnerships, Boosts ‘Revenue Picture’

Lexaria Bioscience, a global innovator in drug delivery platforms, recently announced partnerships with Premier Wellness Science Co., BevNology, AnodGen Bioceuticals, and Valcon Medical A/S According to coverage by Zacks Small-Cap Research, who value Lexaria at $15 per share, the most … Continue reading

Posted in Lexaria Bioscience Corp. LEXX | Leave a comment

MissionIRNewsBreaks – Freight Technologies Inc. (NASDAQ: FRGT) Files F-1 Registration

Freight Technologies (NASDAQ: FRGT) (“Fr8Tech”), a technology company developing solutions to optimize and automate the supply chain process and providing its Fr8App platform for B2B cross-border shipping in the NAFTA region, today announced that it has filed a Form F-1 … Continue reading

Posted in Freight Technologies Inc. FRGT | Leave a comment

MissionIRNewsBreaks – CNS Pharmaceuticals Inc. (NASDAQ: CNSP) Announces Q2 2022 Financial Results, Corporate Update

CNS Pharmaceuticals (NASDAQ: CNSP) is a biopharmaceutical company specializing in the development of novel treatments for primary and metastatic cancers in the brain and central nervous system. The company today reported its financial results for the quarter ended June 30, … Continue reading

Posted in CNS Pharmaceuticals Inc. CNSP | Leave a comment

MissionIRNewsBreaks – SRAX Inc. (NASDAQ: SRAX) Announces Entry into Revolving Credit Facility, Launch of Stock Portfolio Tracker

SRAX (NASDAQ: SRAX) is a financial technology company that unlocks data and insights for publicly traded companies through Sequire, its software-as-a-service (“SaaS”) platform. The company today announced its entry into a revolving credit facility as well as the launch of … Continue reading

Posted in SRAX, Inc. SRAX | Leave a comment

Golden Matrix Group Inc. (NASDAQ: GMGI) Reports a Record $9 Million in Quarterly Revenues

Golden Matrix Group Inc revealed that revenues for the third fiscal quarter ending July 21, 2022, exceeded $9 million The record top-line result marks a significant, 177% increase on a year-over-year basis Management attributed the strong performance to continued growth … Continue reading

Posted in Golden Matrix Group Inc. GMGI | Leave a comment

FingerMotion Inc. (NASDAQ: FNGR), A Company Evolving With the Times

FingerMotion has evolved with the developing need for advanced telecommunications products and services, from SMS and MMS services, to big data insights, and RCS, starting with a focus on China Its latest addition, the device protection program, looks to tap … Continue reading

Posted in FingerMotion Inc. FNGR | Leave a comment

MissionIRNewsBreaks – CNS Pharmaceuticals Inc. (NASDAQ: CNSP) Positioning Berubicin Clinical Development Program for Success

CNS Pharmaceuticals (NASDAQ: CNSP) is currently recruiting patients for a phase II study evaluating the efficacy and safety of Berubicin, its lead drug candidate for treating glioblastoma multiforme (“GBM”), the most aggressive, deadly and treatment-resistant type of cancer that forms … Continue reading

Posted in CNS Pharmaceuticals Inc. CNSP | Leave a comment

More Than Just Energy: EverGen Infrastructure Corp.’s (TSX.V: EVGN) (OTCQB: EVGIF) Renewable Fuels Reducing Greenhouses Gases and Landfill Use

Canada has a goal to reduce greenhouse gas emissions by as much as 45% beneath 2005 levels and 30% below 2020 levels by 2030 Up to 11 million tonnes of Canada’s food production is wasted, waste that could be used … Continue reading

Posted in EverGen Infrastructure Corp. EVGIF | Leave a comment

Lexaria Bioscience Corp. (NASDAQ: LEXX) Inches Closer to DehydraTECH-CBD FDA Evaluation Following Successful Dosing in Multi-Week HYPER-H21-4 Human Clinical Study

Lexaria just completed dosing for its HYPER H21-4 human clinical study that dosed 64 patients aged between 40 and 70 with measured elevated blood pressure, stage 1 and stage 2 hypertension HYPER-H21-4, Lexaria’s most ambitious hypertension clinical study yet, builds … Continue reading

Posted in Lexaria Bioscience Corp. LEXX | Leave a comment